These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Glomerular immune injury in the rat: the influence of angiotensin II and alpha-adrenergic inhibitors.
    Author: Blantz RC, Tucker BJ, Gushwa LC, Peterson OW, Wilson CB.
    Journal: Kidney Int; 1981 Oct; 20(4):452-61. PubMed ID: 6118461.
    Abstract:
    Nephron filtration rate (SNGFR) decreases significantly after the administration of large doses of antiglomerular basement membrane antibody (anti-GBM) as a result of reductions in both nephron (renal) plasma flow (RPF) and the glomerular permeability coefficient (LpA). We have examined the participation of angiotensin II (AII) and alpha-adrenergic activity in this process in paired studies in three groups of Munich-Wistar rats: group 1, control and untreated; group 2, rats receiving continuous infusion of sar1-ala8-AII (1 microgram . kg of body wt-1 . min-1), and AII receptor antagonist; and group 3, rats receiving continuous infusion of phentolamine (27 micrograms . kg body wt-1 . min-1), a dose sufficient to block alpha-adrenergic responses. In group 1, SNGFR decreased from 58 +/- 4 to 35 +/- 6 nl . min-1 . g kidney wt-1 (P less than 0.001) after anti-GMB administration due to reductions in RPF (272 +/- 35 to 170 +/- 52 nl . min-1 . g of kidney wt-1, P less than 0.0001) and LpA (0.13 +/- 0.03 to 0.04 +/- 0.01 nl . sec-1 . g of kidney wt-1 . mm Hg-1, P less than 0.02). In group 2, the sar1-ala8-AII-infused rats. SNGFR decreased to a greater extent than it did in group 1 (P less than 0.01) (55 +/- 2 to 18 +/- 6 nl . min-1 . g of kidney wt-1, P less than 0.005) due to a greater reduction in RPF and a similar decrease in LpA. In group 3, phentolamine infusion prevented the decrease in SNGFR (52 +/- 3 to 52 +/- 4 nl . min-1 . g of kidney wt-1, NS) due primarily to elimination of vasoconstriction and a significantly lesser reduction in LpA (0.10 +/- 0.02 to 0.07 +/- 0.01 nl . sec-1 . g of kidney wt-1 . mm HG-1). There were no morphologic differences after anti-GBM administration that were unique to group 3. Blockade of AII activity does not prevent immune induced vasoconstriction or the reduction in LpA. alpha-Adrenergic blockage (1) prevents acute immune induced vasoconstriction and (2) partially prevents the imune induced reduction in LpA.
    [Abstract] [Full Text] [Related] [New Search]